Haudecoeur R - Search Results

1

Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.

Lazinski LM, Royal G, Robin M, Maresca M, Haudecoeur R. Lazinski LM, et al. Among authors: haudecoeur r. J Med Chem. 2022 Oct 13;65(19):12594-12625. doi: 10.1021/acs.jmedchem.2c01150. Epub 2022 Sep 20. J Med Chem. 2022. PMID: 36126323 Review.

2

Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Haudecoeur R, Ahmed-Belkacem A, Yi W, Fortuné A, Brillet R, Belle C, Nicolle E, Pallier C, Pawlotsky JM, Boumendjel A. Haudecoeur R, et al. J Med Chem. 2011 Aug 11;54(15):5395-402. doi: 10.1021/jm200242p. Epub 2011 Jul 6. J Med Chem. 2011. PMID: 21699179 Free PMC article.

3

Recent advances in the medicinal chemistry of aurones.

Haudecoeur R, Boumendjel A. Haudecoeur R, et al. Curr Med Chem. 2012;19(18):2861-75. doi: 10.2174/092986712800672085. Curr Med Chem. 2012. PMID: 22519399 Review.

4

B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Meguellati A, Ahmed-Belkacem A, Yi W, Haudecoeur R, Crouillère M, Brillet R, Pawlotsky JM, Boumendjel A, Peuchmaur M. Meguellati A, et al. Among authors: haudecoeur r. Eur J Med Chem. 2014 Jun 10;80:579-92. doi: 10.1016/j.ejmech.2014.04.005. Epub 2014 Apr 4. Eur J Med Chem. 2014. PMID: 24835816

5

2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors.

Haudecoeur R, Carotti M, Gouron A, Maresca M, Buitrago E, Hardré R, Bergantino E, Jamet H, Belle C, Réglier M, Bubacco L, Boumendjel A. Haudecoeur R, et al. ACS Med Chem Lett. 2016 Nov 17;8(1):55-60. doi: 10.1021/acsmedchemlett.6b00369. eCollection 2017 Jan 12. ACS Med Chem Lett. 2016. PMID: 28105275 Free PMC article.

6

Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens.

Olleik H, Yahiaoui S, Roulier B, Courvoisier-Dezord E, Perrier J, Pérès B, Hijazi A, Baydoun E, Raymond J, Boumendjel A, Maresca M, Haudecoeur R. Olleik H, et al. Among authors: haudecoeur r. Eur J Med Chem. 2019 Mar 1;165:133-141. doi: 10.1016/j.ejmech.2019.01.022. Epub 2019 Jan 11. Eur J Med Chem. 2019. PMID: 30665143

7

Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.

Roulier B, Pérès B, Haudecoeur R. Roulier B, et al. Among authors: haudecoeur r. J Med Chem. 2020 Nov 25;63(22):13428-13443. doi: 10.1021/acs.jmedchem.0c00994. Epub 2020 Aug 17. J Med Chem. 2020. PMID: 32787103 Review.

8

β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.

Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R. Beato A, et al. Among authors: haudecoeur r. J Med Chem. 2021 Feb 11;64(3):1392-1422. doi: 10.1021/acs.jmedchem.0c01887. Epub 2021 Feb 2. J Med Chem. 2021. PMID: 33528252 Review.

9

Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells.

Roulier B, Rush I, Lazinski LM, Pérès B, Olleik H, Royal G, Fishman A, Maresca M, Haudecoeur R. Roulier B, et al. Among authors: haudecoeur r. Eur J Med Chem. 2023 Jan 15;246:114972. doi: 10.1016/j.ejmech.2022.114972. Epub 2022 Nov 28. Eur J Med Chem. 2023. PMID: 36462443

10

Catechol-mimicking transition-state analogues as non-oxidizable inhibitors of tyrosinases.

Beaumet M, Lazinski LM, Maresca M, Haudecoeur R. Beaumet M, et al. Among authors: haudecoeur r. Eur J Med Chem. 2023 Nov 5;259:115672. doi: 10.1016/j.ejmech.2023.115672. Epub 2023 Jul 20. Eur J Med Chem. 2023. PMID: 37487307 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters